s6y
Company name or ticker
Search
Eloxx Pharmaceuticals, Inc.
3
Germano Geno J: Initial statement of beneficial ownership of securities
Filed
Wednesday, October 21, 2026
Period
Oct 19, 2026
Accession number
0001193125-26-428118
Documents
3
3
EX-24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header